IEEE transactions on neural systems and rehabilitation engineering : a publication of the IEEE Engineering in Medicine and Biology Society · 2026
Decomposed Transfer Entropy for EEG Brain Networks: Parkinson's Disease and Dopaminergic Modulation.
СтатьяНазвание и аннотация: Перевод пока не подготовлен
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Zhu Shumei, Yi Wanyi, Feng Yukun, Xu Han, Bai Dengxuan, Liu Weiguo, Wang Jun
Аннотация
Clarifying the mechanisms of altered brain network communication in Parkinson's disease is crucial, yet conventional connectivity measures do not distinguish whether directed information flow is driven by phase synchrony or spectral amplitude modulation. To address this, we introduce Decomposed Transfer Entropy (DTE), which represents directed information flow as a mechanistic profile comprising phase, spectral, and interaction components. Simulations indicate that DTE identifies distinct coupling types and remains robust under noise; we further benchmark DTE against representative baseline measures and assess parameter sensitivity. Applied to $\theta $ band resting EEG, DTE reveals that the unmedicated (PD-OFF) state is characterized by a phase-dominant reweighting originating from the frontal midline hub Fz; medication shifts this mechanistic composition toward that of healthy reference. Hub-centric composition metrics derived from DTE discriminate PD-OFF from healthy controls, and the normalization of phase dominance relates to motor improvement ( $\Delta $ UPDRS-III). Overall, DTE offers a mechanism-aware perspective on PD pathophysiology, suggesting that therapeutic benefit aligns with normalization of mechanistic composition rather than simple changes in connection strength, and provides a promising route toward mechanism-oriented biomarkers.